Absence of EZH2 Gene Mutation in Chronic Myeloid Leukemia Patients in Blast Crisis |
Chen, Hao-Yue
(Jingjiang People's Hospital, the Seventh Affiliated Hospital of Yangzhou University)
Yao, Hong (Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University) Wu, Ling-Yu (Jingjiang People's Hospital, the Seventh Affiliated Hospital of Yangzhou University) Liu, Can-Jun (Jingjiang People's Hospital, the Seventh Affiliated Hospital of Yangzhou University) Zhu, Jian-Qin (Jingjiang People's Hospital, the Seventh Affiliated Hospital of Yangzhou University) Liu, Chun-Hua (Jingjiang People's Hospital, the Seventh Affiliated Hospital of Yangzhou University) Wang, Wei (Jingjiang People's Hospital, the Seventh Affiliated Hospital of Yangzhou University) Dong, Sha-Sha (Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University) Ping, Na-Na (Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University) Chen, Su-Ning (Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University) Sun, Miao (Jingjiang People's Hospital, the Seventh Affiliated Hospital of Yangzhou University) |
1 | Ernst T, Chase AJ, Score J, et al (2010). Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet, 42, 722-6. DOI ScienceOn |
2 | Ernst T, Pflug A, Rinke J, et al (2012). A somatic EZH2 mutation in childhood acute myeloid leukemia. Leukemia, 26, 1701-3. DOI ScienceOn |
3 | Grossmann V, Bacher U, Kohlmann A, et al (2012). EZH2 mutations and their association with PICALMMLLT10 positive acute leukaemia. Br J Haematol, 157, 387-90. DOI ScienceOn |
4 | Grossmann V, Kohlmann A, Zenger M, et al (2011). A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases. Leukemia, 25, 557-60. DOI ScienceOn |
5 | Guglielmelli P, Biamonte F, Score J, et al (2011). EZH2 mutational status predicts poor survival in myelofibrosis. Blood, 118, 5227-34. DOI ScienceOn |
6 | Jankowska AM, Makishima H, Tiu RV, et al (2011). Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood, 118, 3932-41. DOI |
7 | Makishima H, Jankowska AM, McDevitt MA, et al (2011). CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood, 117, e198-206. DOI ScienceOn |
8 | Makishima H, Jankowska AM, Tiu RV, et al (2010). Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia, 24, 1799-804. DOI ScienceOn |
9 | Morin RD, Johnson NA, Severson TM, et al (2010). Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet, 42, 181-5. DOI ScienceOn |
10 | Zhang SJ, Ma LY,Huang QH, et al (2008). Gain-offunction mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci USA, 105, 2076-81. DOI ScienceOn |